Stericycle (SRCL) Misses Q2 EPS by 27c, Revenues Beat; Offers FY19 EPS Guidance Below Consensus, Affirms FY19 Revenue Outlook
Stericycle (NASDAQ: SRCL) reported Q2 EPS of $0.56, $0.27 worse than the analyst estimate of $0.83. Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)